{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:13:42Z","timestamp":1762546422537,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RS2023-02"],"award-info":[{"award-number":["RS2023-02"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["PKU2024LCXQ001"],"award-info":[{"award-number":["PKU2024LCXQ001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100227"],"award-info":[{"award-number":["82100227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jcyt.2025.04.061","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T02:43:48Z","timestamp":1744944228000},"page":"1137-1144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, risk factors and clinical outcomes of primary prolonged isolated thrombocytopenia following haploidentical transplantation for severe aplastic anemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Ming-Hao","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2025.04.061_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100772","article-title":"Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies","volume":"47","author":"Iftikhar","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0002","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41409-020-01169-7","article-title":"Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges","volume":"56","author":"Xu","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0003","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00277-023-05339-7","article-title":"Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia","volume":"102","author":"Zhao","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0004","article-title":"The incidence, outcomes, and risk factors of secondary poor graft function in haploidentical hematopoietic stem cell transplantation for acquired aplastic anemia","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1705444","article-title":"Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover","volume":"38","author":"Yamazaki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1705203","article-title":"Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0007","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13344","article-title":"Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant","volume":"169","author":"Labrador","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0008","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2010.218","article-title":"Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival","volume":"46","author":"Ram\u00edrez","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0009","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.bbmt.2020.03.024","article-title":"Incidence, risk factors, and outcomes of primary prolonged isolated thrombocytopenia after haploidentical hematopoietic stem cell transplant","volume":"26","author":"Tang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0011","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2017.06.010","article-title":"Recombinant human thrombopoietin promotes platelet engraftment and improves prognosis of patients with myelodysplastic syndromes and aplastic anemia after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Wang","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0012","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0013","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1701499","article-title":"Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation","volume":"22","author":"Bielski","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0014","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0016","article-title":"Low-dose post-transplant cyclophosphamide with G-CSF\/ATG based haploidentical protocol provides favorable outcomes for SAA patients","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-019-0775-9","article-title":"Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study","volume":"12","author":"Xu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0012.2011.01499.x","article-title":"The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation","volume":"26","author":"Huo","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0019","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/17474086.2021.1923475","article-title":"Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings","volume":"14","author":"Xu","year":"2021","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0020","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","article-title":"Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study","volume":"107","author":"Xu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0021","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41409-019-0773-0","article-title":"Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party","volume":"55","author":"Prata","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0022","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00277-015-2436-6","article-title":"Recruitment of CD8 T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1 in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation","volume":"94","author":"Zhang","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0023","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41409-022-01726-2","article-title":"Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children","volume":"57","author":"Wells","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0024","article-title":"Prognostic value of thrombocytopenia in myelodysplastic syndromes after hematopoietic stem cell transplantation","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0025","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3389\/fimmu.2019.02400","article-title":"Platelets and intravascular immunity: guardians of the vascular space during bloodstream infections and sepsis","volume":"10","author":"McDonald","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0026","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbmt.2017.02.021","article-title":"Abnormalities of the bone marrow immune microenvironment in patients with prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Song","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V95.2.487","article-title":"In vitro infection of megakaryocytes and their precursors by human cytomegalovirus","volume":"95","author":"Crapnell","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0028","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1002\/jcp.30335","article-title":"HCMV modulates c-Mpl\/IEX-1 pathway-mediated megakaryo\/thrombopoiesis via PDGFR\u03b1 and \u03b1v\u03b23 receptors after allo-HSCT","volume":"236","author":"Feng","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chom.2019.11.013","article-title":"Human cytomegalovirus miRNAs regulate TGF-\u03b2 to mediate myelosuppression while maintaining viral latency in CD34(+) hematopoietic progenitor cells","volume":"27","author":"Hancock","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0030","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","article-title":"Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation","volume":"22","author":"Akahoshi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0031","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/cid\/ciab298","article-title":"Refractory and resistant cytomegalovirus after hematopoietic cell transplant in the letermovir primary prophylaxis era","volume":"73","author":"Sassine","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0032","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2009.10.004","article-title":"Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"38","author":"Pr\u00e9bet","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0033","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/cells10082051","article-title":"Hematopoietic dysfunction during graft-versus-host disease: a self-destructive process?","volume":"10","author":"M\u00fcskens","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104607","article-title":"Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation","volume":"9","author":"Yao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0035","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.bbmt.2020.06.003","article-title":"Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute graft-versus-host disease","volume":"26","author":"Huang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0036","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41409-018-0380-5","article-title":"Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation","volume":"54","author":"Patel","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0037","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ijlh.13974","article-title":"Effects of CD34 cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease","volume":"45","author":"Wang","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0038","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jtct.2021.11.004","article-title":"Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies","volume":"28","author":"Gauntner","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0039","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0040","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjh.17978","article-title":"Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution","volume":"196","author":"Wu","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0041","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3324\/haematol.2018.193128","article-title":"Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice","volume":"103","author":"Jin","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00277-021-04706-6","article-title":"Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience","volume":"101","author":"Yan","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2025.04.061_bib0043","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41409-019-0435-2","article-title":"Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation","volume":"54","author":"Fu","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925006838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925006838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:10:35Z","timestamp":1762546235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925006838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1465324925006838"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.04.061","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and clinical outcomes of primary prolonged isolated thrombocytopenia following haploidentical transplantation for severe aplastic anemia","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.04.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}